INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1213797500 doctor cancer patient, oncology]( "Gastric Cancer - Global Clinical Trial Landscape (2024)")
Gastric Cancer - Global Clinical Trial Landscape (2024)Discover the latest in gastric cancer research with this detailed report, highlighting new therapies, clinical trials, and future innovations.
-
![medable clinops web thumb]( "Keeping Up With ClinOps: Why And How To Improve Delivery")
Keeping Up With ClinOps: Why And How To Improve DeliveryIndustry experts discuss the concept of a trial platform as a service and how it can accelerate and enhance the day-to-day functions of clinical operations throughout the entire lifecycle of a study.
-
![greenphire webinar snip]( "3 Keys To A Successful Patient Convenience Strategy")
3 Keys To A Successful Patient Convenience StrategyListen in as subject matter experts discuss three key components of a successful patient convenience strategy.
-
![GettyImages-178381149_animal_testing]( "FDA Animal Rule: Overview And Impact On Drug Development")
FDA Animal Rule: Overview And Impact On Drug DevelopmentStreamline drug approvals using the Animal Rule, which allows for well-controlled animal studies when human trials aren't possible. Learn more about this expedited pathway.
-
Ensuring Completeness, Accuracy, And Consistency From Source To Archive8/22/2023
Discover how proficient TMF handling can proactively address potential pitfalls, fostering a state of preparedness for regulatory evaluations.
-
An Adept Travel Solution For Clinical Trial Participants9/29/2023
Unearth how ConneX simplifies participant retention and engagement by aligning travel arrangements with study and participant needs, all while adhering to sponsor policies and requirements.
-
Building Opinion Leader Relationships In A Post-Pandemic World4/20/2023
Learn why it’s important to build strong relationships with opinion leaders in the healthcare industry, as well as how to establish and maintain them.
-
Cross-Border M&A: 10 Key Trends To Watch In 20234/17/2023
Many observers believe deal volume will remain buoyant throughout 2023. The need for access to cash is expected to continue to drive M&A decision-making. Heightened regulatory scrutiny, supply chain weakness, and consolidation are a few of the trends to watch for the remainder of the year.
-
Clinical Trial Startup: Insights From The Industry11/17/2023
Uncover key survey findings gleaned from the perspectives of over 500 clinical researchers regarding technological trends and recommendations for enhancing the overall site experience.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-804420186 nurse doctor data]( "Only Elligo Mitigates Research Risk")
Uncertainty is inherent in clinical research. Uncover new strategies and solutions to alleviate risk so clinical teams can confidently and quickly bring products to market.
-
IQVIA Biotech virtual trials speed recruitment, heighten retention, and improve data quality by leveraging our transformative technology, unparalleled data, and therapeutic expertise. With experience designing and delivering complex hybrid studies and 100% virtual trials across the United States, Europe and Asia, IQVIA Biotech helps emerging biopharma and biotech customers accelerate timelines and achieve study goals.
-
![woman writing on glass with colleagues in background ps]( "'One Size Fits All' Has Never Applied In Healthcare")
Connect your clinical program with strong scientific and medical expertise, deep therapeutic insights, and unrivaled experience to find a direct route from breakthrough science to new therapies.
-
![CSSI Tech]( "Clinical Trial Recruitment Reinvented")
Clinical Site Services (CSSi) is the industry leader in delivering strategic patient recruitment and enrollment solutions to study sites, sponsors and CROs.
-
TrialScope Clinical Trial Registry Manager (CTRM) delivers the proven solutions clinical trial sponsors need to centralize, track, register, and comply with clinical trial disclosure processes, mitigating compliance risks while giving them greater control over their own clinical trial disclosure reputation.
